July 13, 2020 / 6:52 PM / 21 days ago

Pharmas restart drug trials after declines during pandemic, Medidata finds

July 13 (Reuters) - Pharmaceutical companies have ramped up clinical trials in the past month, rebounding from a steep decline in activity following the start of the coronavirus outbreak, though activity remains below pre-pandemic levels, according to new research shared with Reuters.

The research, which was prepared by clinical trial consulting firm Medidata, shows that new subjects entered trials globally in June at a 30% lower rate than they did before the pandemic. But that is significantly higher than the roughly 70% decline in new subject starts in April.

Reporting by Carl O'Donnell; Editing by Leslie Adler

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below